Sign Up Today and Learn More About INBRAIN Neuroelectronics Stock
Invest in or calculate the value of your shares in INBRAIN Neuroelectronics or other pre-IPO companies through EquityZen's platform.
INBRAIN Neuroelectronics Stock (IINN)
INBRAIN Neuroelectronics is a BCI therapeutics company using graphene to build the least invasive and most intelligent neural platform
About INBRAIN Neuroelectronics Stock
Founded
2019
Industries
Software, Artificial Intelligence, Data and Analytics
INBRAIN Neuroelectronics Press Mentions
Stay in the know about the latest news on INBRAIN Neuroelectronics
New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $400B Brain-Computer Interface (BCI) Market
globenewswire • Apr 01, 2025
New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $400B Brain-Computer Interface (BCI) Market
marketscreener • Apr 01, 2025
Neurology Devices Market is Expected to Reach USD 22,335.5 Million by 2035, Growing at 6.7% CAGR | Fact.MR Report
globenewswire • Mar 10, 2025
Catalonia: A biotech hub going from strength to strength, with Barcelona at its core
labiotech • Mar 07, 2025
Electrode device
patents • Feb 07, 2025
INBRAIN Neuroelectronics Management
Leadership team at INBRAIN Neuroelectronics
CEO and co founder
Carolina Aguilar
Board Member
Josep L.l. Sanfeliu
Join now and verify your accreditation status to gain access to:
- INBRAIN Neuroelectronics Current Valuation
- INBRAIN Neuroelectronics Stock Price
- INBRAIN Neuroelectronics Management
- Available deals in INBRAIN Neuroelectronics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- INBRAIN Neuroelectronics Cap Table and Funding History by Share Class and Liquidity Preferences
- INBRAIN Neuroelectronics Revenue and Financials
- INBRAIN Neuroelectronics Highlights
- INBRAIN Neuroelectronics Business Model
- INBRAIN Neuroelectronics Risk Factors
- INBRAIN Neuroelectronics Research Report from SACRA Research
Trading INBRAIN Neuroelectronics Stock
How to invest in INBRAIN Neuroelectronics stock?
Accredited investors can buy pre-IPO stock in companies like INBRAIN Neuroelectronics through EquityZen funds. These investments are made available by existing INBRAIN Neuroelectronics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell INBRAIN Neuroelectronics stock?
Shareholders can sell their INBRAIN Neuroelectronics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
